The IL-2-based immunocytokines that showed positive results in preclinical lymphoma studies include L19-IL2 in NHL, HI-Leu 16-IL2 in lymphoma and HRS3scFv-IL12-Fc-IL12 in Hodgkin lymphoma. This evidence concerns the gene IL2 and non-Hodgkin lymphoma.